| 1 |
Long B, Koyfman A. Best clinical practice: emergency medicine management of stable monomorphic ventricular tachycardia. J Emerg Med. 2017; 52(4):484-92.
doi: 10.1016/j.jemermed.2016.09.010
|
| 2 |
Florek JB, Girzadas D. Amiodarone. In: StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482154 .
|
| 3 |
Hashmi A, Keswani NR, Kim S, Graham DY. Hepatic dysfunction in patients receiving intravenous amiodarone. South Med J. 2016; 109(2):83-6.
doi: 10.14423/SMJ.0000000000000413
pmid: 26840961
|
| 4 |
Clark TJ, Suby-Long T. Computed tomography of acute heart failure: a novel case and literature review. Radiol Case Rep. 2015; 10(1):1065.
doi: 10.2484/rcr.v10i1.1065
|
| 5 |
Maleki M, Vakilian F, Amin A. Liver diseases in heart failure. Heart Asia. 2011; 3(1):143-9.
doi: 10.1136/heartasia-2011-010023
pmid: 27326014
|
| 6 |
Lewis JH, Ranard RC, Caruso A, Jackson LK, Mullick F, Ishak KG, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology. 1989; 9(5):679-85.
pmid: 2785079
|
| 7 |
Simon JB, Manley PN, Brien JF, Armstrong PW. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med. 1984; 311(3):167-72.
doi: 10.1056/NEJM198407193110308
|
| 8 |
Paudel R, Dogra P, Suman S, Acharya S, Matta J. Acute liver and renal failure: a rare adverse effect exclusive to intravenous form of amiodarone. Case Rep Crit Care. 2016; 2016:5232804.
doi: 10.1155/2016/5232804
pmid: 27672457
|
| 9 |
Chen CC, Wu CC. Acute hepatotoxicity of intravenous amiodarone: case report and review of the literature. Am J Ther. 2016; 23(1):e260-3.
doi: 10.1097/MJT.0000000000000149
|
| 10 |
Pye M, Northcote RJ, Cobbe SM. Acute hepatitis after parenteral amiodarone administration. Br Heart J. 1988; 59(6):690-1.
pmid: 3395527
|
| 11 |
Gluck N, Fried M, Porat R. Acute amiodarone liver toxicity likely due to ischemic hepatitis. Isr Med Assoc J. 2011; 13(12):748-52.
|
| 12 |
Rätz Bravo AE, Drewe J, Schlienger RG, Krähenbühl S, Pargger H, Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med. 2005; 33(1):128-34.
doi: 10.1097/01.CCM.0000151048.72393.44
|
| 13 |
Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA. Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. Drug Healthc Patient Saf. 2013; 5:191-8.
|
| 14 |
Verhovez A, Elia F, Riva A, Ferrari G, Aprà F. Acute liver injury after intravenous amiodarone: a case report. Am J Emerg Med. 2011; 29(7):843.e5-6.
|
| 15 |
Cataldi A, Gonella D, Robutti N, Siri M, Buonocore S, Odetti P. Hepatotoxicity after intravenous amiodarone. Aging Clin Exp Res. 2008; 20(6):593-6.
pmid: 19179845
|
| 16 |
Diab OA, Kamel J, Abd-Elhamid AA. Predictors of intravenous amiodarone induced liver injury. Egypt Heart J. 2017; 69(1):45-54.
doi: 10.1016/j.ehj.2016.05.001
pmid: 29622954
|
| 17 |
Rhodes A, Eastwood JB, Smith SA. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle? Gut. 1993; 34(4):565-6.
pmid: 8491409
|
| 18 |
Maker AV, Orgill DP. Rapid acute amiodarone-induced hepatotoxicity in a burn patient. J Burn Care Rehabil. 2005; 26(4):341-3.
pmid: 16006841
|
| 19 |
Lahbabi M, Aqodad N, Ibrahimi A, Lahlou M, Aqodad H. Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy. World J Hepatol. 2012; 4(6):196-8.
doi: 10.4254/wjh.v4.i6.196
pmid: 22761971
|
), Farnam Kazi1, Niel Chen1, Mohamed Mohamed1, Jasmine Chacko2, Nils Guttenplan3, Vincent Nguyen4
